Top Markets
#1 Bedrock Bedrock +42.69%
#2 Talus Network Talus Network +24.65%
#3 API3 API3 +20.65%
#4 CyberDEX CyberDEX +19.21%
#5 iExec RLC iExec RLC +18.52%
#6 Radicle Radicle +16.37%
#7 The Bitcoin Bull The Bitcoin Bull +16.37%
#8 VeThor VeThor +13.05%
#9 Verus Coin Verus Coin +11.08%
#10 Rollbit Coin Rollbit Coin +10.44%
Coin of the day
Bedrock Bedrock
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Cell Source, Inc. Cell Source, Inc.

Cell Source, Inc.

CLCS
Classement en actions #28220
Cell Source, Inc. is a biotechnology firm dedicated to creating cell-based... Cell Source, Inc. is a biotechnology firm dedicated to creating cell-based therapies centered on regulating immune tolerance. The company's flagship innovation is its Veto Cell immune system management technology, an advanced immune tolerance platform capable of selectively suppressing specific immune responses. This Veto Cell technology finds application in numerous areas, including enhancing the acceptance of stem cell transplants for conditions like lymphoma, leukemia, and multiple myeloma. Furthermore, it is utilized in treating end-stage kidney disease, various other non-malignant organ diseases, and a spectrum of both cancerous and non-malignant illnesses. Founded in 2012, Cell Source, Inc. maintains its corporate headquarters in New York, New York.
Prix de l'action
$0.4
Dernière synchronisation: 2026-10-02
Capitalisation boursière
$27.18M
Changement (1 jour)
-14.88%
Changement (1 an)
8.11%
Pays
US
Échange Cell Source, Inc. (CLCS)

Catégorie

Healthcare
Ratio P/B pour Cell Source, Inc. (CLCS)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Cell Source, Inc., le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour Cell Source, Inc. de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.5558 -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 11.2791 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 4.0142 -
AU
Argenx SE Argenx SE
Argenx SE
ARGX.US
 7.082 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH